5-s-cysteinyl-3,4-dihydroxyphenylacetic acid has been researched along with levodopa in 1 studies
| Studies (5-s-cysteinyl-3,4-dihydroxyphenylacetic acid) | Trials (5-s-cysteinyl-3,4-dihydroxyphenylacetic acid) | Recent Studies (post-2010) (5-s-cysteinyl-3,4-dihydroxyphenylacetic acid) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | 5-s-cysteinyl-3,4-dihydroxyphenylacetic acid (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halliwell, B; Jenner, P; Spencer, JP; Whiteman, M | 1 |
1 other study(ies) available for 5-s-cysteinyl-3,4-dihydroxyphenylacetic acid and levodopa
| Article | Year |
|---|---|
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caspase 3; Caspases; Catecholamines; Cell Survival; Cells, Cultured; Cysteine; Cysteinyldopa; DNA; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Intracellular Fluid; Levodopa; Methamphetamine; Neurons; Purines; Pyrimidines; Rats; Reactive Oxygen Species | 2002 |